Generated by AI
Solid Biosciences Inc. is a precision genetic medicine company focused on developing gene therapy candidates for rare neuromuscular and cardiac diseases. Solid Biosciences Inc. advances a pipeline that includes programs for Duchenne muscular dystrophy, Friedreich’s ataxia, catecholaminergic polymorphic ventricular tachycardia, and certain forms of dilated cardiomyopathy. Its work centers on addressing severe genetic disorders through targeted therapies designed to act on the underlying disease biology rather than on symptoms alone. The company serves the biotechnology and rare-disease markets, where its research and clinical development efforts are aimed at conditions with significant unmet medical need. Headquartered in Charlestown, Massachusetts, Solid Biosciences Inc. operates as a life sciences company with a focus on translating genetic science into treatments for patients with serious inherited diseases.
Website500 Rutherford Avenue
Charlestown, MA, 02129
United States
The latest articles about SLDB.
Summary of Jul 8's posts. Generated by AI.
Summary of Mar 1's posts. Generated by AI.
Summary of Feb 18's posts. Generated by AI.
Investors talking about SLDB also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.